Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Pfizer Applies Integrated Technology for Cell-Line Development of Proprietary Antibodies

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.
Sep 25, 2013

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.

Exploring Single-Use Systems for Fill-Finish Operations

The need to develop a final formulation process for a parenteral product sensitive to stainless-steel gave Patheon the opportunity to evaluate the potential of single-use technology in fill-finish operations.
Sep 25, 2013

The need to develop a final formulation process for a parenteral product sensitive to stainless-steel gave Patheon the opportunity to evaluate the potential of single-use technology in fill- finish operations.

Granulation Method and Process Monitoring Matter

The characteristics of tableted solid dosage drugs often depend on the granulation process, so selecting the most appropriate granulation technique and monitoring the process are crucial
Sep 25, 2013

The characteristics of tableted solid dosage drugs often depend on the granulation process, so selecting the most appropriate granulation technique and monitoring the process are crucial

Laser Headspace Analysis Advantageous for Monitoring Sterile Fill-Finish Operations

Measuring headspace gas composition and pressure allows sterile product manufacturers to simultaneously monitor important quality parameters rapidly and nondestructively.
Sep 25, 2013

Measuring headspace gas composition and pressure allows sterile product manufacturers to simultaneously monitor important quality parameters rapidly and nondestructively.

Sigma-Aldrich, The Scripps Research Institute Translating Research into Commercial Applications

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.
Sep 11, 2013

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.

Avoiding Glass Delamination with Early Product/Container Testing

Determining the potential for glass delamination before a product goes to market is the best way to ensure product safety and prevent expensive recalls.
Sep 11, 2013

Determining the potential for glass delamination before a product goes to market is the best way to ensure product safety and prevent expensive recalls.

Boehringer Ingelheim Pharmaceuticals Uses Two-Dimensional Ultrahigh-Pressure Liquid Chromatography in Process Development

2D-UHPLC enabled the simultaneous analysis of reaction conversion and enantiomeric excess in asymmetric hydrogenations
Sep 11, 2013

2D-UHPLC enabled the simultaneous analysis of reaction conversion and enantiomeric excess in asymmetric hydrogenations

Mechanical Control with Foam Granulation Well-Suited for Pharmaceutical Manufacturing

Foam granulation is much easier to control under mechanical dispersion conditions, which is where most industrial processes operate.
Sep 11, 2013

Foam granulation is much easier to control under mechanical dispersion conditions, which is where most industrial processes operate.

Novartis Making Moves to Increase Biologics Manufacturing Capability

Novartis half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.
Sep 11, 2013

Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here